Offsets deal reached to fund FDA, NIH 'Cures' bill
This article was originally published in Scrip
Executive Summary
Republican and Democratic leaders of the House Energy and Commerce Committee late on 20 May said they had reached a deal on how they will pay for the expected $13bn costs of implementing the provisions in the proposed 21st Century Cures Act (HR 6) – a bill aimed at overhauling the US biomedical enterprise, which is intended to speed up the discovery, development and approval processes for therapies, devices and diagnostics.